Terms: = Liver cancer AND DEK, D6S231E, 7913, ENSG00000124795, P35659 AND Prognosis
4 results:
1. The Effect of the Histone Chaperones HSPA8 and dek on Tumor Immunity in Hepatocellular Carcinoma.
Yang C; Shao Y; Wang X; Wang J; Wang P; Huang C; Wang W; Wang J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768989
[TBL] [Abstract] [Full Text] [Related]
2. dek Is a Potential Biomarker Associated with Malignant Phenotype in Gastric cancer Tissues and Plasma.
Lee KF; Tsai MM; Tsai CY; Huang CG; Ou YH; Hsieh CC; Hsieh HL; Wang CS; Lin KH
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766266
[TBL] [Abstract] [Full Text] [Related]
3. High expression of dek is associated with poor prognosis in hepatocellular carcinoma.
Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
[TBL] [Abstract] [Full Text] [Related]
4. Overexpression of dek gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract] [Full Text] [Related]
